Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):379S-389S.

PMID:
11189689
2.

Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.

Gohagan JK, Broski K, Gren LH, Fouad MN, Higgins D, Lappe K, Ogden S, Shambaugh V, Pinsky PF, O'Brien B, Yurgalevich S, Riley T, Wright P, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):187-93. Review.

PMID:
26435288
3.

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK.

J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. Review.

4.

The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results.

Gohagan JK, Prorok PC, Greenwald P, Kramer BS.

Rev Recent Clin Trials. 2015;10(3):173-80. Review.

PMID:
26238115
5.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
6.

Minority issues in prostate disease.

French DB, Jones LA.

Med Clin North Am. 2005 Jul;89(4):805-16. Review.

PMID:
15925651
7.

Building Successful Relationships in the PLCO Cancer Screening Trial.

Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S.

Rev Recent Clin Trials. 2015;10(3):181-6. Review.

PMID:
26238208
8.

Prostate cancer and black men.

Brawley OW.

Semin Urol Oncol. 1998 Nov;16(4):184-6. Review.

PMID:
9858323
9.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):233-7. Review.

PMID:
26238116
10.

Prostate cancer screening: what we have learned from the PLCO and ERSPC trials.

La Rochelle J, Amling CL.

Curr Urol Rep. 2010 May;11(3):198-201. doi: 10.1007/s11934-010-0109-5. Review.

PMID:
20425627
11.

PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies.

Black A, Huang WY, Wright P, Riley T, Mabie J, Mathew S, Ragard L, Hermansen S, Yu K, Pinsky P, Prorok PC, Freedman ND, Hoover RN.

Rev Recent Clin Trials. 2015;10(3):238-45. Review.

PMID:
26435289
12.

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

Smith RA, Cokkinides V, Brawley OW.

CA Cancer J Clin. 2009 Jan-Feb;59(1):27-41. doi: 10.3322/caac.20008. Review.

13.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

PMID:
12953083
14.

Racial differences in prostate cancer treatment outcomes: a systematic review.

Peters N, Armstrong K.

Cancer Nurs. 2005 Mar-Apr;28(2):108-18. Review.

PMID:
15815180
15.

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB, Madalinska JB, Church T, Crawford D, Essink-Bot ML, Goel V, de Koning HJ, Määttänen L, Pentikäinen T.

Eur J Cancer. 2001 Nov;37(17):2154-60. Review.

PMID:
11677101
16.

Randomized trial results did not resolve controversies surrounding prostate cancer screening.

Hoffman RM.

Curr Opin Urol. 2010 May;20(3):189-93. doi: 10.1097/MOU.0b013e3283383b55. Review.

PMID:
20224414
17.

Prostate cancer screening in African American men: barriers and methods for improvement.

Reynolds D.

Am J Mens Health. 2008 Jun;2(2):172-7. doi: 10.1177/1557988307312784. Epub 2008 Jan 23. Review.

PMID:
19477781
18.

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):194-9. Review.

PMID:
26238206
19.

[Examples of screening investigations].

Eickhoff A, Hahn A, Riemann JF.

Internist (Berl). 2008 Jun;49(6):660, 662-4, 666-8, 670-2. doi: 10.1007/s00108-008-2163-3. Review. German.

PMID:
18461294
20.

The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource.

Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C.

Rev Recent Clin Trials. 2015;10(3):212-22. Review.

PMID:
26238117

Supplemental Content

Support Center